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Objective: Extended cervical mediastinoscopy (ECM) is a method
for sampling aortopulmonary window (APW) mediastinal lymph
nodes. In this study, the efficacy of integrated positron emission
tomography/computed tomography (PET/CT) was compared with
ECM for the detection of APW lymph node metastasis.
Methods: Fifty-five patients diagnosed of non-small cell lung can-
cer in whom APW or hilar lymph nodes had been reported to be
positive on PET/CT, and/or who had had central tumor and/or in
whom ECM had been performed for mediastinal staging due to the
presence of APW lymph nodes larger than 1 cm in diameter on the
CT between 2005 and 2009, were retrospectively analyzed. All
patients underwent PET/CT scanning.
Results: Thirty-eight patients were identified as cN0 by standard
cervical mediastinoscopy/ECM, and lobectomy, pneumonectomy,
and exploratory thoracotomy were performed on 19, 13, and six of
these patients, respectively. Mediastinal lymphadenectomy revealed
APW lymph node metastases in four patients (ECM false negative).
Seventeen patients identified as cN2 by mediastinoscopy, APW
lymph node metastasis was present in nine, whereas eight had
mediastinal lymph node metastasis that could only be accessed by
standard cervical mediastinoscopy but had no APW lymph node
metastasis were excluded from the analysis. Sensitivity, specificity,
negative predictive value, positive predictive value, and accuracy of
ECM/PET/CT were calculated as 0.69/0.53, 1/0.91, 0.89/0.83,
1/0.70, and 0.91/0.80, respectively.
Conclusions: ECM, which is an effective technique used in the
determination of APW lymph node metastasis, was enough to rule
out nodal disease with negative predictive value. PET/CT does not
reduce the need for invasive procedures in detecting APW lymph
node metastasis.
Key Words: Lung cancer, Diagnosis (includes staging, imaging,
fiducials), Mediastinal lymph nodes, Positron emission tomography,
PET/CT.
(J Thorac Oncol. 2011;6: 1713–1719)
The currently used standard cervical mediastinoscopy (SCM)was performed for the first time by Carlens1 in 1959. SCM
has become widely used since the mid-1960s with the routine
application of mediastinoscopy in the mediastinal staging of
patients with non-small cell lung cancer (NSCLC) by Pearson.2
As the evaluation of the aortopulmonary window (APW) is not
possible by SCM, Specht3 (in 1965) and Kirschner4 (in 1971)
showed that biopsy of anterior mediastinal lesions could be
performed by “expanded” mediastinoscopy and “extended” me-
diastinoscopy, respectively. In 1987, Ginsberg et al.5 defined the
technique of extended cervical mediastinoscopy (ECM), which
was performed through the same incision used in SCM, and
stated that this technique allowed for the assessment of APW
lymph nodes.
Integrated positron emission tomography/computed to-
mography (PET/CT), which reveals the tumor bioactivities, is
a technique commonly used for preoperative mediastinal
staging of patients with lung carcinoma. Although there are
studies reporting that PET/CT could reduce the need for
invasive staging, and thus reduce the use of SCM by replacing
mediastinoscopy,6 there are also studies indicating that inva-
sive staging and mediastinoscopy are still the gold standard
for mediastinal staging.7–9 Nevertheless, there are no studies
comparing invasive mediastinal staging with PET/CT for
APW lymph nodes (station 5; so called subaortic or aorto-
pulmonary node and station 6; so called paraaortic or ascend-
ing aortic or phrenic node10).
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The aim of this study was to compare the efficacy of
PET/CT with ECM, particularly in determining the APW
lymph node metastasis, and to determine whether PET/CT
would reduce the need for invasive procedures specific to
these lymph nodes.
PATIENTS AND METHODS
Patient Population
From April 2005 to May 2009, 207 patients with the
diagnosis of NSCLC of the left lung and hospitalized for
invasive mediastinal staging at the 1st Surgery Clinic of
Yedikule Thoracic Surgery and Chest Disease Education and
Research Hospital were investigated. Fifty-five patients un-
derwent ECM who had
Y Central tumor located in the left hemithorax and adja-
cent to the mediastinal region and/or
Y An APW lymph node larger than 1 cm (at the smallest
diameter) and/or
Y The APW and/or hilar lymph nodes had been reported to
be positive by PET/CT, were retrospectively analyzed.
All patients had been diagnosed with NSCLC by means
of bronchoscopy or transthoracic fine needle aspiration bi-
opsy and considered to be operable according to the results of
the physical examination, posteroanterior chest radiograph,
thoracic CT, PET/CT, pulmonary function tests (ventilation-
perfusion scintigraphy, if necessary), electrocardiography (ef-
fort electrocardiography and angiography, if necessary), cra-
nial magnetic resonance imaging, and complete blood count
and biochemical analysis. Neither of the patients had type I
diabetes mellitus nor had undergone neoadjuvant chemother-
apy, radiotherapy, or chemoradiotherapy for any reason.
Radiologic Imaging of PET/CT and Evaluation
PET/CT had been performed to all patients at three
different PET/CT center using a multidetector CT integrated
high-resolution PET/CT scanner (Siemens Biograph LSO
HI-REZ PET/CT scanner, Chicago, IL). The patients had
fasted for at least 4 hours and were well hydrated before the
procedure, and their blood glucose levels were measured.
After verification of the blood glucose level less than 150
mg/dL, 370 to 555 MBq of 18F-fluorodeoxyglucose (FDG)
was administered intravenously. After a rest of 60 to 90
minutes in a comfortable environment, whole-body PET
imaging was performed on patients. On PET/CT images,
mediastinal lymph nodes with a FDG uptake greater than the
normal background activity of the mediastinal blood pool
(approximately SUVmax  2–2.5) was considered suspi-
cious for malignancy and recorded on the basis of each
stations.
Surgical Technique
ECM was simultaneously performed on all patients
through the same cervical incision used for SCM within a
maximum of 30 days (19.0  4.0) following the imaging of
PET/CT. Using SCM, pretracheal and paratracheal regions
were accessed by blunt dissection toward the carina, and
upper (station 2) and lower (station 4) paratracheal lymph
nodes, as well as subcarinal lymph nodes, were routinely
explored and visible lymph nodes were sampled. As defined
by Ginsberg et al.,5 blunt dissection with the index finger was
performed through the SCM incision between the innominate
artery and the left carotid artery over the aortic arch. The
fascia was incised, and the innominate triangle was accessed
through a passage under the innominate vein over the aortic
arch. Subsequently, the mediastinoscope was inserted through
the same incision and passed through the tunnel created by
finger dissection toward the left sternoclavicular joint. APW
lymph nodes were accessed and sampled. A posteroanterior
chest radiograph was performed on all patients postoperatively,
and complications such as hoarseness, pneumothorax, surgical
wound infection, or other complications developed secondary to
the mediastinoscopy, if any, were recorded.
Thoracotomy and Systematic Nodal Dissection
After the histopathological examination after mediasti-
noscopy, patients with cN2 disease were referred to the
Oncology Department for treatment. Anatomic tumor resec-
tion and systematic nodal dissection by thoracotomy were
performed on patients who were identified as cN0 by medi-
astinoscopy. The lymph node stations (5, 6, and 7) were also
sampled in patients in whom anatomic tumor resection could
not be performed for any reason. Resected materials and the
lymph nodes were examined histopathologically by same and
specific pathologist.
Data Collection and Statistical Analysis
The patients were divided into three groups (Table 1).
Group 1 consisted of patients who had been classified as cN0
according to the results of SCM/ECM (n  38) and had
undergone thoracotomy for tumor resection and systematic
nodal dissection (SCM negative/ECM negative); group 2
consisted of patients who had been classified as cN2 by
mediastinoscopy and had APW lymph node metastasis (SCM
negative or positive/ECM positive) (n  9); and group 3
consisted of patients who had been classified as cN2 by
mediastinoscopy, had mediastinal lymph node metastasis that
could only be accessed by SCM but had no APW lymph node
metastasis (SCM positive/ECM negative) (n  8). Patients in
group 3 (in which SCM was positive and ECM was negative)
were excluded from the analysis for the purpose of evaluating
only metastatic disease found at the APW lymph nodes
TABLE 1. The Results of Histopathological Examination of
Mediastinal Lymph Nodes Detected by Standard and
Extended Cervical Mediastinoscopy
Tumor Location
cN0,
Group 1
SCM ()
ECM ()
cN2
Group 2
Group 3
SCM ()
ECM ()
SCM ()
ECM ()
SCM ()
ECM ()
Upper lobe (n  35) 24 3 4 4
Central (n  20) 14 2 — 4
Total (n  55) 38 5 4 8
SCM, standard cervical mediastinoscopy; ECM, extended cervical mediastinoscopy.
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during ECM. Patients in groups 2 and 3 were referred to the
Oncology Department for treatment. The PET/CT findings
were compared with the results of ECM and thoracotomy
regarding APW lymph nodes in groups 1 and 2, and the
sensitivity, specificity, negative predictive value (NPV), pos-
itive predictive value (PPV), accuracy, false negativity, and
unsuspected APW lymph nodes disease were calculated using
standard formulations with 95% confidence intervals (CIs).
Data were analyzed by Statistical Package for the Social
Sciences (SPSS) for Windows (version 15.0; SPSS Inc.,
Chicago, IL). The Student’s t test and the 2 test were used
for comparisons between the groups (Fisher’s exact test was
used if the expected cell count in one or more cells was less
than 5). p values less than 0.05 were considered statistically
significant.
RESULTS
All patients (n 55) were men, and their mean age was
56.7 years (range, 40–76 years). Histopathologic tumor type
was squamous cell carcinoma in 28 patients (50.9%), adeno-
carcinoma in 18 patients (32.7%), adenosquamous carcinoma
in two patients (3.6%), large cell carcinoma in two patients
(3.6%), and unclassified NSCLC in 13 patients (9.0%).
Localization of the tumor was left upper lobe in 35
patients (63.6%). Twenty-eight of these patients had a nega-
tive FDG uptake for APW lymph nodes, whereas the remain-
ing seven patients had a positive FDG uptake for APW lymph
nodes. Tumor was located centrally in 20 patients (36.4%).
Six of these patients had a positive FDG uptake, whereas the
remaining 14 patients had a negative FDG uptake for APW
lymph nodes.
Thorax CT revealed APW lymph nodes with pathologic
size in 28 patients (50.9%). Nineteen of these patients had a
negative PET scan for APW lymph nodes, whereas the
remaining nine patients had a positive PET scan for APW
lymph nodes. No enlarged APW lymph nodes were observed
in the remaining 27 patients (49.1%). Nevertheless, four of
these patients had a positive PET scan for APW lymph nodes.
PET/CT reported that there was APW lymph node
involvement in 13 patients (23.7%) regardless of the size.
Three of these 13 patients with the adenopathy limited to the
paratracheal or subcarinal space without infiltrating the
paraortic or subaortic spaces were excluded from the study as
mentioned earlier. Metastasis was detected by ECM or tho-
racotomy in 7 of 10 patients reported as APW lymph nodes
involvement by PET/CT (PET true positive, n  7/10). APW
lymph nodes metastasis was demonstrated by ECM in five
patients (station 5 in three patients and stations 5 and 6 in two
patients) and by thoracotomy in two patients (station 5 in
one patient and stations 5 and 6 in one patient). APW lymph
node metastasis was not detected by ECM or thoracotomy in
3 of 10 patients reported as APW lymph nodes involvement
by PET/CT (PET false positive, n  3/10; Figure 1).
PET/CT reported that 42 patients (76.3%) had negative
APW lymph nodes regardless of the nodes size. Five of these
42 patients with the adenopathy limited to the paratracheal or
subcarinal space without infiltrating the paraortic or subaortic
spaces were also excluded from the study as mentioned
earlier. In 31 of the remaining 37 patients, no APW lymph
node metastasis was detected by ECM or thoracotomy (PET
true negative, n  31/37). Nevertheless, APW lymph node
metastasis was detected by ECM or thoracotomy in six of
these patients (PET false negative, n 6/37; Figure 1). APW
lymph nodes metastasis was demonstrated by ECM in four
patients (station 5 in two patients, station 6 in one patient, and
stations 5 and 6 in one patient) and by thoracotomy in two
patients (station 5 in two patients). Integrated PET/CT
showed an overall sensitivity of 53.8% (95% CI: 0.26–0.80),
specificity of 91.1% (95% CI: 0.81–1), PPV of 70.0% (95%
CI: 0.41–0.98), NPV of 83.7% (95% CI: 0.71–0.95), and
accuracy of 80.8% (95% CI: 0.69–0.92) for the detection of
APW lymph nodes metastases on a per-patient basis (Figure
1, Table 2). Unsuspected APW lymph node disease was
found in six patients (PET/CT false negative for APW lymph
nodes; 16.2%). Patients with adenocarcinoma showed higher
unsuspected APW lymph nodes metastatic rates than those
FIGURE 1. PET/CT results of the patients with or without
lymph node metastasis accessed by ECM. APW, aortopulmo-
nary window; PET/CT, positron emission tomography/com-
puted tomography; FN, false negative; TN, true negative;
TP, true positive; FP, false positive; SCM, standard cervical
mediastinoscopy; ECM, extended cervical mediastinoscopy;
APW cN2, APW positive by PET/CT; APW cN0, APW negative
by PET/CT; group 3, consisted of patients who had been
classified as cN2 by mediastinoscopy and had mediastinal
lymph node metastasis that could only be accessed by SCM,
without APW lymph node metastasis (SCM positive/ECM
negative). Sensitivity  TP/TP  FN  7/7  6  53.8%;
NPV  TN/TN  FN  31/31  6  83.7%; accuracy 
TP  TN/TP  TN  FN  FP  7  31/7  31  6  3 
80.8%; PPV  TP/TP  FP  7/7  3  70%; and specific-
ity  TN/TN  FP  31/31  3  91.1%.
TABLE 2. Accuracy Measures of Extended Cervical
Mediastinoscopy and Positron Emission Tomography-
Computed Tomography
Sensitivity Specificity NPV PPV Accuracy
ECM (%) 69.2 100.0 89.4 100.0 91.4
PET/CT (%) 53.8 91.1 83.7 70.0 80.8
ECM, extended cervical mediastinoscopy; PET/CT, positron emission tomography-
computed tomography; NPV, negative predictive value; PPV, positive predictive value.
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with other NSCLC cell types, although this difference was
not statistically significant (p  0.074). Accuracy of PET/CT
showed no difference for tumor localization (p  0.970).
Mediastinoscopy sampled a total of 326 nodal stations
(mean: 5.92, range: 4–7). ECM was successful at harvesting
one or more APW lymph nodes in 53 patients (96.3%)
(stations 5 and 6 in 43 patients, only station 6 in seven
patients, and only station 5 in three patients).
Mediastinal lymph node metastasis (cN2) was observed
in 17 patients by mediastinoscopy. Eight patients were ex-
cluded from the study due to the presence of mediastinal
lymph node metastasis that could only be accessed by SCM
(SCM positive/ECM negative; group 3) as mentioned earlier
(Table 1). APW lymph nodes metastasis was demonstrated
by ECM in nine patients (station 5 in five patients, stations 5
and 6 in three patients, and station 6 in one patient) (ECM
true positive, n  9/47). Tumor localization was left upper
lobe in seven and central in two of nine patients. In four of
these nine patients with the adenopathy limited to the paraor-
tic or subaortic spaces, there was no infiltration of paratra-
cheal or subcarinal space (only positive in ECM but negative
in SCM; 4/55, 7.2%).
Thoracotomy was performed on 38 patients due to the
absence of mediastinal lymph node metastasis (group 1;
Table 1). Lobectomy was performed to 19 patients (in three
patients with en bloc resection of thoracic wall and in two
patients with bronchial sleeve resection), whereas pneumo-
nectomy was performed to 13 patients (in two patients with
en bloc resections of thoracic wall and in one patient with
intrapericardial ligation of the vessels). Moreover, six pa-
tients underwent exploratory thoracotomy. Two of these six
patients were considered unresectable because of the direct
mediastinal infiltration, which was not accessible through
ECM. In the remaining of four patients, pneumonectomy was
the required operation to achieve complete resection but was
contraindicated because of two patients had multiple N2
(stations 5 and 8 in one patient and stations 5 and 9 in one
patient) and two patients had cardiopulmonary instability.
Thoracotomy was successful at dissecting one or more
APW lymph nodes in 35 patients (92.1%) (stations 5 and 6 in
30 patients, only station 5 in four patients, and only station 6
in one patient). Thoracotomy was not successful at dissecting
one or more APW lymph nodes in three patients (7.9%). Two
patients were considered unresectable who had cardiopulmo-
nary instability. One patient who underwent lobectomy had
no APW lymph nodes detected in the APW space.
The pathological results of systematic nodal dissection
revealed metastasis at station 8 in one patient and at station 9
in another patient (lymphatic nodal group not accessible by
ECM; considered true-negative results) and at APW lymph
nodes in four patients (ECM false negative, n 4/38; 10.5%;
Figure 2). False negativity was only determined in station 5,
and tumor was in the upper lobe in these patients. Lobectomy
was performed to two of these four patients. The remaining
two patients underwent exploratory thoracotomy because
they had multiple N2 (stations 5 and 8 in one patient and
stations 5 and 9 in one patient), and pneumonectomy was the
required operation to achieve complete resection. Patients
with adenocarcinoma showed higher false-negative rates for
APW lymph nodes than those with other NSCLC cell types,
although this difference was not statistically significant (p 
0.592). There were no false-negative cases of mediastinos-
copy at the subcarinal nodal station.
According to these results, the sensitivity, specificity,
PPV, NPV, and accuracy of ECM were calculated as 69.3%
(95% CI: 0,44–0.94), 100%, 100%, 89.4% (95% CI: 0.79–
0.99), and 91.4% (95% CI: 0.81–1), respectively (Table 2,
Figure 2). Four patients (7.2%) had complications due to
mediastinoscopy, including hoarseness in three patients, and
pneumothorax in one patient.
Thirteen patients (27.6%) with N2 disease had APW
node involvement, which was demonstrated by ECM in nine
patients and by thoracotomy in four patients. APW lymph
nodes metastasis rates for upper lobe tumors were higher than
that for central tumors, although this difference was not
statistically significant (p  0.79). Patients with adenocarci-
noma showed higher APW lymph nodes metastasis rates than
those with squamous cell carcinoma, although this difference
was not statistically significant (p  0.492). Among all
patients, the number of patients with APW lymph node
metastasis alone was eight (17%) of which four patients were
detected by ECM and four were detected by thoracotomy.
DISCUSSION
Maximum effort should be performed for accurate
staging as mediastinal staging is the most important prognos-
tic indicator and the criteria for treatment selection in NSCLC
without distant metastasis. Recently, many surgeons recom-
mend pulmonary resection in the case of regression after
neoadjuvant therapy in the presence of cN2. Nevertheless,
patients with N2 disease form a heterogeneous group, includ-
ing upper, aortic, and lower mediastinal lymph nodes. More-
over, it is clear that there is a difference regarding survival
between the cN2 patients with bulky lymph nodes and pN2
FIGURE 2. Histopathological findings of the patients after
standard and extended cervical mediastinoscopy. SCM,
standard cervical mediastinoscopy; ECM, extended cervi-
cal mediastinoscopy, *group 1, **group 2, ***group 3;
sensitivity  TP/TP  FN  9/9  4  69.2%; NPV 
TN/TN  FN  34/34  4  89.4%; Accuracy  TP 
TN/TP  TN  FN  FP  9  34/9  34  4  91.4%.
FN, false negative; TN, true negative; TP, true positive; FP,
false positive.
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patients with microscopic lymph nodes detected after resec-
tion. This diversity has led to a variety of treatment recom-
mendations and controversy. In some studies, patients with
nodal involvement of lymph node station 5 or 6 have been
reported to have a better survival than those with other pN2s
but similar survival as patients with hilar and mediastinal
lymph node involvement.11,12 Patterson et al.12 have sug-
gested that lymph nodes in that region should not be consid-
ered as mediastinal lymph nodes and that pulmonary resec-
tion should be performed regardless of lymph node
involvement. It may be considered acceptable not to perform
invasive staging of APW because better survival is obtained
by surgical resection in the presence of involvement of these
stations. Compared with other studies, Cerfolio et al.13 re-
ported a better survival rate in patients with lung cancer
metastasized to APW lymph nodes, in which surgery was
performed along with restaging after induction chemoradio-
therapy. Also we consider biopsy-proven metastatic carci-
noma of no. 5 and no. 6 lymph nodes as pN2 (multilevel and
advanced disease) and thus unresectable. Thus, there is a
conflict in identification or elimination of stations 5 and 6
according to presence of metastases before the resection. In
this regard, the selection of the method to be performed in the
staging of APW lymph nodes will be a second issue to
resolve.
Although SCM, which is the most commonly used
invasive diagnostic method for mediastinal staging, is still
considered the gold standard in sampling of superior medi-
astinal lymph nodes, it fails to evaluate APW. In the late
1980s, the evaluation of APW by ECM was proposed by
Ginsberg et al.5 as an alternative method for SCM combined
with left anterior mediastinotomy (Chamberlain procedure)14
and for thoracoscopy. Nevertheless, the studies investigating
ECM are limited.15–18
The NPV obtained in this study (89%) and in the
previously published series has been considered adequate for
ruling out the disease, as the importance of mediastinal
staging is double: diagnosis and ruling out nodal disease
(Table 3). In this study, the sensitivity of ECM was similar to
those published previously. Nevertheless, sensitivity deter-
mined in the series of Lopez et al.15 and Freixinet et al.16 was
slightly higher compared with those determined in our study.
This may be attributed to the use of modified ECM method or
CT examination of enlarged lymph nodes in their selected
patient groups and thereby easy detection of lymph nodes by
ECM. The presence of all false-negative metastases in sub-
aortic (station 5) lymph nodes of which detection and biopsy
are difficult may explain the low sensitivity determined in this
study. Although the invasive methods evaluating the APW
were considered valuable in combination with SCM,19 the
overall sensitivity for the superior mediastinum and APW
was lower in previously published series than those in this
study (Table 3). This could be due to the determination of
false negativity for the subcarinal region by other authors,
whereas no subcarinal false negativity was determined in
this study.
In left anterior mediastinotomy, after performing an
anterior incision 5 to 8 cm in size, the costochondral junction
should be excised. The aortopulmonary region can be ac-
cessed by retracting the pleura laterally; however, this may
cause the opening of the pleura, and also the manipulation
and exploration can be difficult as the majority of the patients
have central or upper lobe tumors. Additionally, this method
requires an anterior incision that results in poor esthetic
appearance, and the possibility in the development of left
internal mammary artery damage in patients with a high
potential need for bypass. Video-assisted thoracic surgery
(VATS) is not used as commonly as SCM and ECM in
staging of bronchogenic carcinoma, and there is no specific
analysis regarding its indications. Considering the need for
single lung ventilation, the possible difficulties due to pleural
adhesions and the potential difficulties in the subsequent
thoracotomy due to disruption in the integrity of pleura and
the need for postoperative follow-up with thoracic drainage
for at least 1 day it is suggested that VATS is not superior to
ECM in the evaluation of the APW. Most of the patients who
underwent ECM were discharged home on the same day of
operation with a mean hospitalization time of 8 hours as we
previously describe.18 Freixinet et al.16 reported that ECM is
superior both to VATS and left anterior mediastinotomy.
In this study, the complication rate was 7.2%, and the
most common complication was hoarseness. Considering
the complications of ECM to be pneumothorax, mediasti-
nitis, and surgical wound infection, the complications
observed in this study may be attributed to the radical
superior mediastinal lymph node sampling performed by
SCM rather than ECM.
Recently, there has been an increasing interest in
PET/CT staging, which is the most commonly used nonin-
vasive method for mediastinal staging. Early studies revealed
TABLE 3. The Accuracy Measures of Extended Cervical Mediastinoscopy (ECM) and ECM in
Combination with Standard Cervical Mediastinoscopy
Ginsberg et al.5
(n  100)
Lopez et al.15
(n  50)
Freixinet et al.16
(n  106)
Call et al.17
(n  156)
Present Study
(n  55)
Sensitivity 0.69/0.69 0.83/0.75 0.81/0.76 0.62/0.54 0.69/0.80
Specificity 1/1 1/1 1/1 1/1 1/1
PPV 1/1 1/1 1/1 1/1 1/1
NPV 0.89/0.89 0.97/0.92 0.91/0.82 0.94/0.92 0.89/0.89
Accuracy 0.91/0.91 0.98/0.95 0.95/0.88 0.95/0.92 0.91/0.92
Prevalence (%) 29 13 34.4 13.4 27.6
PPV, positive predictive value; NPV, negative predictive value.
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that accuracy of PET/CT was higher than CT and PET in the
noninvasive mediastinal staging.20 Nevertheless, the efficacy
of PET/CT in the intrathoracic lymph node staging is still
contradictory due to presence of various results concerning its
efficacy in determining mediastinal lymph node metastasis.6–9,21
For instance, based on a study including 51 patients, it has
been reported that patients with negative PET/CT for medi-
astinal lymph nodes can be operated without invasive medi-
astinal staging.6 Despite the fewer false-negative results with
improvements in PET technology, Lee et al.21 established a
significant increase in false-positive results, and thus, they
indicated that PET/CT should be used as an adjunct to clinical
staging and that surgical staging was still the gold standard in
NSCLC. Furthermore, another study demonstrated that the
NPV of PET/CT was low in patients who had pathological
lymph nodes on CT and negative PET/CT results.22 Although
there are numerous publications comparing SCM with PET or
PET/CT, a comparison between ECM with PET/CT has not
been investigated. The sensitivity of ECM has been reported
to be increased only in the series of Call et al.17 whose cases
were selected by means of PET or PET/CT (routine ECM,
45%; selective ECM, 75%).
In this study, the sensitivity (53%), specificity (91%),
NPV (83%), PPV (70%), and accuracy (80%) of PET/CT
for the evaluation of APW lymph nodes were lower than
those of ECM. The PPV of PET/CT found in this study
was consistent with the literature.7,23 In this study, com-
plete thoracic lymphadenectomy was performed both for
APW and other mediastinal/hilar lymph nodes, and the
histopathological examination was performed by the same
and specific pathologist in all patients. Thus, pN2 patients
with microscopic lymph nodes, which can easily be missed
by PET/CT, could be identified. Bille´ et al.7 reported that
station 5 was the second mediastinal lymph node station
with the highest rate of PET/CT inaccuracy and that the
sensitivity and NPV of PET/CT for APW lymph nodes
were to be similar to those of this study. Cerfolio et al.23
reported that the most common locations for N2 disease that
was undetected by PET/CT were the subcarinal and APW
stations. They suggested that mediastinal staging should be
performed in patients who were clinically classified as stage
IB and stage II NSCLC, even if the nodes were negative on
PET/CT scanning. Also in a recent study, NPV for APW
lymph nodes was calculated 76% with patients with early
stage-cN0 lung cancer.24 Therefore, although PET/CT can
indicate an appropriate area for biopsy and be used as a guide
for APW region, it cannot replace a tissue biopsy. Thus, we
consider that surgical staging is the gold standard, and
PET/CT is a supplementary method in staging.
In conclusion, ECM is a useful technique that has an
adequate NPV and accuracy in determining metastasis to
APW lymph nodes in patients with NSCLC and can be easily
applied by an experienced team. Even though PET/CT re-
veals negative results, ECM is recommended in patients with
upper lobe or central NSCLC with APW lymph nodes larger
than 1 cm (in the smallest diameter) due to the high rate of
APW lymph node metastasis. As PET/CT did not provide an
adequate NPV and sensitivity in determining APW metasta-
sis, PET/CT failed to reduce the need for invasive procedures
for the APW lymph nodes.
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